Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker CRVL
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | Steven J. Hamerslag Director | CRVL CorVel Corp. | Sale | 11,000 | $84.04 | $924.5K Sale | Form 4 ↗ |
| Nov 9, 2026 | R. Judd Jessup Director | CRVL CorVel Corp. | Sale | 6,939 | $83.01 | $576.0K Sale | Form 4 ↗ |
| Sep 14, 2026 | Corstar Holdings Inc 10% owner | CRVL CorVel Corp. | Sale | 127,824 | $70.16 | $9.0M Sale | Form 4 ↗ |
| Sep 11, 2026 | Corstar Holdings Inc 10% owner | CRVL CorVel Corp. | Sale | 30,925 | $69.05 | $2.1M Sale | Form 4 ↗ |
| Sep 4, 2026 | Corstar Holdings Inc 10% owner | CRVL CorVel Corp. | Sale | 14,538 | $68.76 | $999.6K Sale | Form 4 ↗ |
| Sep 3, 2026 | Corstar Holdings Inc 10% owner | CRVL CorVel Corp. | Sale | 51,713 | $68.91 | $3.6M Sale | Form 4 ↗ |
| Sep 1, 2026 | R. Judd Jessup Director | CRVL CorVel Corp. | Sale | 4,023 | $70.07 | $281.9K Sale | Form 4 ↗ |
| Aug 27, 2026 | R. Judd Jessup Director | CRVL CorVel Corp. | Sale | 1,262 | $70.64 | $89.1K Sale | Form 4 ↗ |
| Aug 26, 2026 | R. Judd Jessup Director | CRVL CorVel Corp. | Sale | 1,562 | $70.71 | $110.4K Sale | Form 4 ↗ |
| Aug 20, 2026 | Jennifer Yoss Vice President of Accounting | CRVL CorVel Corp. | Sale | 2,100 | $70.92 | $148.9K Sale | Form 4 ↗ |
| Jun 12, 2026 | Maxim Shishin Chief Information Officer | CRVL CorVel Corp. | Sale | 2,250 | $60.59 | $136.3K Sale | Form 4 ↗ |
| Jun 12, 2026 | Michael G. Combs CEO & President | CRVL CorVel Corp. | Sale | 500 | $60.79 | $30.4K Sale | Form 4 ↗ |
| Jun 11, 2026 | Michael G. Combs CEO & President | CRVL CorVel Corp. | Sale | 7,000 | $60.55 | $423.9K Sale | Form 4 ↗ |
| Jun 10, 2026 | Michael G. Combs CEO & President | CRVL CorVel Corp. | Sale | 7,000 | $61.38 | $429.7K Sale | Form 4 ↗ |
| Jun 9, 2026 | Michael G. Combs CEO & President | CRVL CorVel Corp. | Sale | 7,000 | $60.90 | $426.3K Sale | Form 4 ↗ |
| Jun 9, 2026 | Jeffrey J. Michael Director, 10% owner | CRVL CorVel Corp. | Sale | 9,000 | $60.98 | $548.8K Sale | Form 4 ↗ |
| Jun 8, 2026 | Michael G. Combs CEO & President | CRVL CorVel Corp. | Sale | 7,000 | $60.22 | $421.5K Sale | Form 4 ↗ |
| May 26, 2026 | Jennifer Yoss Vice President of Accounting | CRVL CorVel Corp. | Sale | 900 | $61.02 | $54.9K Sale | Form 4 ↗ |
| May 26, 2026 | Jennifer Yoss Vice President of Accounting | CRVL CorVel Corp. | Sale | 141 | $61.02 | $8,604 Sale | Form 4 ↗ |
| May 26, 2026 | Jennifer Yoss Vice President of Accounting | CRVL CorVel Corp. | Sale | 958 | $61.02 | $58.5K Sale | Form 4 ↗ |
| Mar 16, 2026 | Maxim Shishin Chief Information Officer | CRVL CorVel Corp. | Sale | 2,400 | $54.00 | $129.6K Sale | Form 4 ↗ |
| Mar 9, 2026 | Michael G. Combs CEO & President | CRVL CorVel Corp. | Sale | 8,013 | $54.00 | $432.7K Sale | Form 4 ↗ |
| Feb 13, 2026 | Steven J. Hamerslag Director | CRVL CorVel Corp. | Sale | 10,000 | $48.41 | $484.1K Sale | Form 4 ↗ |
| Feb 12, 2026 | Steven J. Hamerslag Director | CRVL CorVel Corp. | Sale | 10,000 | $47.17 | $471.7K Sale | Form 4 ↗ |
| Nov 19, 2025 | Mark E. Bertels EVP - Risk Management Services | CRVL CorVel Corp. | Sale | 1,200 | $72.35 | $86.8K Sale | Form 4 ↗ |
| Nov 11, 2025 | R. Judd Jessup Director | CRVL CorVel Corp. | Sale | 7,076 | $76.94 | $544.4K Sale | Form 4 ↗ |
| Nov 10, 2025 | R. Judd Jessup Director | CRVL CorVel Corp. | Sale | 210 | $76.27 | $16.0K Sale | Form 4 ↗ |
| Nov 7, 2025 | R. Judd Jessup Director | CRVL CorVel Corp. | Sale | 3,247 | $76.20 | $247.4K Sale | Form 4 ↗ |
| Sep 11, 2025 | Maxim Shishin Chief Information Officer | CRVL CorVel Corp. | Sale | 9,000 | $87.82 | $790.4K Sale | Form 4 ↗ |
| Sep 11, 2025 | Maxim Shishin Chief Information Officer | CRVL CorVel Corp. | Sale | 9,000 | $87.82 | $790.4K Sale | Form 4 ↗ |
| Sep 8, 2025 | Brandon O'Brien Chief Financial Officer | CRVL CorVel Corp. | Sale | 1,764 | $91.54 | $161.5K Sale | Form 4 ↗ |
| Sep 8, 2025 | Corstar Holdings Inc 10% owner | CRVL CorVel Corp. | Sale | 70,000 | $91.46 | $6.4M Sale | Form 4 ↗ |
| Sep 2, 2025 | Corstar Holdings Inc 10% owner | CRVL CorVel Corp. | Sale | 40,000 | $88.85 | $3.6M Sale | Form 4 ↗ |
| Aug 20, 2025 | Maxim Shishin Chief Information Officer | CRVL CorVel Corp. | Sale | 12,000 | $89.16 | $1.1M Sale | Form 4 ↗ |
| Aug 19, 2025 | Mark E. Bertels EVP - Risk Management Services | CRVL CorVel Corp. | Sale | 900 | $89.17 | $80.3K Sale | Form 4 ↗ |
| Aug 7, 2025 | Alan Hoops Director | CRVL CorVel Corp. | Sale | 1,500 | $88.58 | $132.9K Sale | Form 4 ↗ |
| Aug 7, 2025 | Alan Hoops Director | CRVL CorVel Corp. | Sale | 500 | $88.58 | $44.3K Sale | Form 4 ↗ |
| Jun 9, 2025 | Brandon O'Brien Chief Financial Officer | CRVL CorVel Corp. | Sale | 3,957 | $108.46 | $429.2K Sale | Form 4 ↗ |
| Jun 9, 2025 | Maxim Shishin Chief Information Officer | CRVL CorVel Corp. | Sale | 2,400 | $108.09 | $259.4K Sale | Form 4 ↗ |
| Jun 9, 2025 | Alan Hoops Director | CRVL CorVel Corp. | Sale | 3,000 | $108.28 | $324.8K Sale | Form 4 ↗ |
| Jun 5, 2025 | Brandon O'Brien Chief Financial Officer | CRVL CorVel Corp. | Sale | 2,211 | $110.64 | $244.6K Sale | Form 4 ↗ |
| Jun 3, 2025 | Michael G. Combs CEO & President | CRVL CorVel Corp. | Sale | 2,816 | $112.36 | $316.4K Sale | Form 4 ↗ |
| Jun 2, 2025 | R. Judd Jessup Director | CRVL CorVel Corp. | Sale | 6,351 | $110.41 | $701.2K Sale | Form 4 ↗ |
| May 30, 2025 | R. Judd Jessup Director | CRVL CorVel Corp. | Sale | 150 | $111.76 | $16.8K Sale | Form 4 ↗ |
| May 29, 2025 | Jennifer Yoss Vice President of Accounting | CRVL CorVel Corp. | Sale | 1,050 | $111.39 | $117.0K Sale | Form 4 ↗ |
| May 29, 2025 | R. Judd Jessup Director | CRVL CorVel Corp. | Sale | 687 | $111.25 | $76.4K Sale | Form 4 ↗ |
| May 27, 2025 | Mark E. Bertels EVP - Risk Management Services | CRVL CorVel Corp. | Sale | 900 | $113.34 | $102.0K Sale | Form 4 ↗ |
| May 27, 2025 | Alan Hoops Director | CRVL CorVel Corp. | Sale | 3,000 | $113.05 | $339.1K Sale | Form 4 ↗ |
| May 27, 2025 | R. Judd Jessup Director | CRVL CorVel Corp. | Sale | 935 | $113.50 | $106.1K Sale | Form 4 ↗ |
| Apr 9, 2025 | Jeffrey J. Michael Director, 10% owner | CRVL CorVel Corp. | Sale | 8,609 | $117.31 | $1.0M Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:47 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances